05 Jun 2015 Print
The benefit of reduced mortality extends to women screened at age 70–74 years, according to the International Agency for Research on Cancer (IARC), which is part of the UN World Health Organization (WHO).
A summary of the assessment carried out by the group, which considered emerging technologies, clinical breast examination, and breast self-examination, was published yesterday in the New England Journal of Medicine.
“Careful consideration of both the benefits and harms of mammography screening shows a net benefit from inviting women 50–69 years old,” Dr. Lauby-Secretan, an IARC scientist and the Responsible Officer for the Handbooks Series, said in a news release.
“The significant reduction in breast cancer mortality observed in this age group outweighs the effects of overdiagnosis and other adverse effects,” she added.
An evaluation of data from studies conducted in high-income countries (in Australia, Europe, and North America) showed that women 50–69 years of age who attended mammography screening had a reduction in breast cancer mortality of around 40 per cent.
“Providing early access to effective diagnosis and treatment in developed and developing countries is critical to reduce breast cancer mortality globally,” said Dr. Christopher Wild, the Director of IARC.
However, evidence for the effectiveness of screening women in the younger age group of 40–49 years was considered limited.
Among the group’s conclusions is that there is sufficient evidence that mammography screening detects breast cancers that would never have been diagnosed or caused harm if the women had not been screened.
Evaluation of the current literature also showed that there is sufficient evidence that clinical breast examination is associated with the detection of smaller and earlier-stage tumours.
Numerous studies have investigated the beneficial effects of screening modalities other than mammography.
Breast cancer is the most common cause of death from cancer in women worldwide, the second leading cause of death from cancer in women in high-income countries, and the leading cause of death from cancer in low- and middle-income countries, where a high proportion of women present with advanced disease, which has a poor prognosis.
Established risk factors for breast cancer include age, a family or personal history of breast cancer or pre-cancerous lesions, genetic predisposition, reproductive factors, hormonal treatment, alcohol consumption, obesity, and exposure to ionizing radiation.
- New U of T measure calls for non-medical masks or face coverings in indoor public spaces: Study
- Identify and address ‘real needs’ to recover from COVID-19, UN rights expert urges
- Russian COVID-19 cases top 700,000
- ‘New dynamic’ needed to overcome negative impacts of COVID-19 worldwide
- WHO to issue new brief on airborne transmission, following ‘active engagement’ with scientists